Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Marc Zimmerman

Marc Zimmerman is Senior Director, Clinical Affairs at Veranex. He possesses over 16+ years of experience in medical device industry with CROs and Sponsor companies alike. A strategic and operational leader for U.S. and international clinical study programs, he brings extensive medical device clinical research experience ranging from First-In-Human/feasibility studies to pivotal trials in pursuit of medical device commercialization to our medical device clients, including special expertise with U.S. IDE studies of Class II (510(k) and De Novo) and Class III (PMA) medical devices, ranging from surgery-enabling technologies to short-term and long-term implants.